Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

about

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

Item

http://www.wikidata.org/entity/Q47245866

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@en

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@nl

type

Item

label

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@en

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@nl

prefLabel

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@en

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@nl

P1476

Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.

@en

P2093

Elin Pernevik

http://www.w3.org/2001/XMLSchema#string

Jessica Holmén-Larsson

http://www.w3.org/2001/XMLSchema#string

Johan Gobom

http://www.w3.org/2001/XMLSchema#string

Karl T Hansson

http://www.w3.org/2001/XMLSchema#string

P2860

Human cerebrospinal fluid peptidomics

Alzheimer's disease.

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease.

High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis.

Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes.

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.

A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.

P31

scholarly article

P356

10.3791/56244

http://www.w3.org/2001/XMLSchema#string

P433

130

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29286401

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

5755527

http://www.w3.org/2001/XMLSchema#string